Literature DB >> 7498254

The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine.

T S Shippenberg1, C Heidbreder.   

Abstract

A conditioned place preference paradigm was used to determine whether: (i) prior exposure to cocaine results in an enhancement of its rewarding effects, and (ii) the delta-opioid receptor antagonist naltrindole can prevent the development of this response. Rats received daily injections of saline or cocaine (10.0 mg/kg i.p.) for 5 days in the colony room. Additional animals received naltrindole (0.03-0.3 mg/kg s.c.), lithium chloride (20 mg/kg s.c.) or vehicle prior to i.p. injections. Conditioning sessions (2 drug; 2 vehicle) commenced 3 days later. Cocaine (1.0-10.0 mg/kg) was ineffective as a conditioning stimulus in saline pre-exposed rats. In cocaine pre-exposed animals, however, doses of 5.0 and 10.0 mg/kg cocaine resulted in significant drug-induced place preferences. Significant cocaine-induced place preferences were also observed in animals which had received lithium chloride with the cocaine treatment regimen. In animals which had received naltrindole together with the chronic cocaine treatment regimen, cocaine failed to produce a conditioned response. These data demonstrate that the repeated administration of cocaine results in an enhancement of its rewarding effects (e.g. sensitization) and that this phenomenon is prevented by a delta-opioid receptor antagonist. Furthermore, the finding that naltrindole does not modify the acute rewarding effects of cocaine suggests a specific role of delta-opioid receptors in the sensitization process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498254     DOI: 10.1016/0014-2999(95)00185-n

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.

Authors:  H Zhang; H R Kranzler; B-Z Yang; X Luo; J Gelernter
Journal:  Mol Psychiatry       Date:  2007-07-10       Impact factor: 15.992

2.  Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists.

Authors:  Rama Pichika; Douglas M Jewett; Philip S Sherman; John R Traynor; Stephen M Husbands; James H Woods; Michael R Kilbourn
Journal:  Nucl Med Biol       Date:  2010-07-24       Impact factor: 2.408

3.  Higher sensitivity to the conditioned rewarding effects of cocaine and MDMA in High-Novelty-Seekers mice exposed to a cocaine binge during adolescence.

Authors:  A Mateos-García; C Roger-Sánchez; M Rodriguez-Arias; J Miñarro; M A Aguilar; C Manzanedo; M C Arenas
Journal:  Psychopharmacology (Berl)       Date:  2014-06-08       Impact factor: 4.530

4.  Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine.

Authors:  Toni S Shippenberg; Vladimir I Chefer; Alexis C Thompson
Journal:  Biol Psychiatry       Date:  2008-10-31       Impact factor: 13.382

5.  Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation.

Authors:  José A Morón; Srinivas Gullapalli; Chirisse Taylor; Achla Gupta; Ivone Gomes; Lakshmi A Devi
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

6.  Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration.

Authors:  Marta Valenza; Roberto Picetti; Vadim Yuferov; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Neuropharmacology       Date:  2016-01-09       Impact factor: 5.250

7.  (+)-Morphine attenuates the (-)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat.

Authors:  Maia Terashvili; Hsiang-En Wu; Emma T Schwasinger; Kuei-Chun Hung; Jau-Shyong Hong; Leon F Tseng
Journal:  Eur J Pharmacol       Date:  2008-03-29       Impact factor: 4.432

Review 8.  A neuropeptide-centric view of psychostimulant addiction.

Authors:  B Boutrel
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

Review 9.  The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.

Authors:  Kelley C O'Donnell; Todd D Gould
Journal:  Neurosci Biobehav Rev       Date:  2007-04-13       Impact factor: 8.989

10.  Synergistic activity between the delta-opioid agonist SNC80 and amphetamine occurs via a glutamatergic NMDA-receptor dependent mechanism.

Authors:  Kelly E Bosse; Emily M Jutkiewicz; Kristin N Schultz-Kuszak; Omar S Mabrouk; Robert T Kennedy; Margaret E Gnegy; John R Traynor
Journal:  Neuropharmacology       Date:  2013-09-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.